Jonathan H Clarke

9PUBLICATIONS
28CO-AUTHORS
Neurology and neuromuscular diseasesCheminformatics and quantitative structure-activity relationshipsCentral nervous systemClinical pharmacology and therapeuticsProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 19, 2025
Development of Purine and Pyrrolopyrimidine Scaffolds as Potent, Selective, and Brain Penetrant NUAK1 Inhibitors.

Gregory G Aldred, Helen K Boffey, Henriette M G Willems

|Feb 19, 2025
Development of the Pyrido[2,3-d]pyrimidin-7(8H)-one Scaffold toward Potent and Selective NUAK1 Inhibitors.

Timothy P C Rooney, Gregory G Aldred, David Winpenny

|Jan 04, 2024
p-tau Ser356 is associated with Alzheimer's disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003.

Lewis W Taylor, Elizabeth M Simzer, Claire Pimblett

|Oct 20, 2023
The rational design of ARUK2007145, a dual inhibitor of the α and γ isoforms of the lipid kinase phosphatidylinositol 5-phosphate 4-kinase (PI5P4K).

Gregory G Aldred, Timothy P C Rooney, Henriette M G Willems

|May 30, 2023
Identification of ARUK2002821 as an isoform-selective PI5P4Kα inhibitor.

Henriëtte M G Willems, Simon Edwards, Helen K Boffey

|Dec 14, 2022
The Identification of Potent, Selective, and Brain Penetrant PI5P4Kγ Inhibitors as In Vivo-Ready Tool Molecules.

Timothy P C Rooney, Gregory G Aldred, Helen K Boffey

Pageof 2

Frequent Collaborators

7 joint publications

John Skidmore

6 joint publications

Stephen P Andrews

5 joint publications

Henriëtte M G Willems

4 joint publications

Helen K Boffey